Significant Ownership of Adjuvant Global Health Technology Fund, L.P.

Signature - Title
/s/ Kabeer Aziz - Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Adjuvant Global Health Technology Fund, L.P..

Notify me when Adjuvant Global Health Technology Fund, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Adjuvant Global Health Technology Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ANTX AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share 7.9% $3.06M 2.37M Adjuvant Capital GP, L.P. Dec 31, 2024

Schedules 13D/G Reported by Adjuvant Global Health Technology Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.